Hepatitis Monthly

Published by: Kowsar

Seroprevalence of Hepatitis A among Children and Young Adults Residing in Tehran, Iran: Implication for HAV Vaccination

Amitis Ramezani 1 , Mohammad Reza Aghasadeghi 2 , Setareh Mamishi 3 , Shahram Sabeti 4 , Farahnaz Bidari - Zerehpoosh 4 , Mohammad Banifazl 5 , Anahita Bavand 1 , Sahar Shadanlou 1 and Arezoo Aghakhani 1 , *
Authors Information
1 Clinical Research Department, Pasteur Institute of Iran, Tehran, Iran
2 Hepatitis & AIDS Department, Pasteur Institute of Iran, Tehran, Iran
3 Pediatric Infectious Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
4 Pathology Ward, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
5 Iranian Society for Support of Patients with Infectious Diseases, Tehran, Iran
Article information
  • Hepatitis Monthly: April 2018, 18 (4); e66915
  • Published Online: May 12, 2018
  • Article Type: Research Article
  • Received: January 30, 2018
  • Revised: April 24, 2018
  • Accepted: April 28, 2018
  • DOI: 10.5812/hepatmon.66915

To Cite: Ramezani A, Aghasadeghi M R, Mamishi S, Sabeti S, Bidari - Zerehpoosh F, et al. Seroprevalence of Hepatitis A among Children and Young Adults Residing in Tehran, Iran: Implication for HAV Vaccination, Hepat Mon. 2018 ; 18(4):e66915. doi: 10.5812/hepatmon.66915.

Abstract
Copyright © 2018, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Franco E, Meleleo C, Serino L, Sorbara D, Zaratti L. Hepatitis A: Epidemiology and prevention in developing countries. World J Hepatol. 2012;4(3):68-73. doi: 10.4254/wjh.v4.i3.68. [PubMed: 22489258]. [PubMed Central: PMC3321492].
  • 2. World Health Organization. Hepatitis A vaccines. Wkly Epidemiol Rec. 2000;75(5):38-44. [PubMed: 10693358].
  • 3. Vilibic-Cavlek T, Kucinar J, Ljubin-Sternak S, Kolaric B. Seroepidemiology of hepatitis a in the croatian population. Hepat Mon. 2011;11(12):997-9. doi: 10.5812/kowsar.1735143X.756. [PubMed: 22368685]. [PubMed Central: PMC3282034].
  • 4. Jacobsen KH, Koopman JS. The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns. Int J Epidemiol. 2005;34(3):600-9. doi: 10.1093/ije/dyi062. [PubMed: 15831565].
  • 5. Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine. 2010;28(41):6653-7. doi: 10.1016/j.vaccine.2010.08.037. [PubMed: 20723630].
  • 6. Cuthbert JA. Hepatitis A: old and new. Clin Microbiol Rev. 2001;14(1):38-58. doi: 10.1128/CMR.14.1.38-58.2001. [PubMed: 11148002]. [PubMed Central: PMC88961].
  • 7. Ciocca M. Clinical course and consequences of hepatitis A infection. Vaccine. 2000;18 Suppl 1:S71-4. [PubMed: 10683554].
  • 8. Letaief A, Kaabia N, Gaha R, Bousaadia A, Lazrag F, Trabelsi H, et al. Age-specific seroprevalence of hepatitis a among school children in central Tunisia. Am J Trop Med Hyg. 2005;73(1):40-3. [PubMed: 16014829].
  • 9. Melnick JL. History and epidemiology of hepatitis A virus. J Infect Dis. 1995;171 Suppl 1:S2-8. [PubMed: 7876643].
  • 10. Hosseini Shokouh SJ, Dadashi A, Abiri M, Zohrevand I, Eshraghian A, Khoshdel A, et al. HAV Immunity in Iranian Medical Students. Hepat Mon. 2015;15(3). e26219. doi: 10.5812/hepatmon.26219. [PubMed: 25825590]. [PubMed Central: PMC4359362].
  • 11. Yun H, Lee HJ, Yoon Y, Kim K, Kim S, Shin MH, et al. Seroepidemiology of hepatitis a infection in northeastern china, Korea, and Japan. Osong Public Health Res Perspect. 2012;3(1):31-5. doi: 10.1016/j.phrp.2012.01.005. [PubMed: 24159484]. [PubMed Central: PMC3738681].
  • 12. World Health Organization. WHO position paper on hepatitis A vaccines. Wkly Epidemiol Rec. 2012;87:261-76. [PubMed: 22905367].
  • 13. Montazam SH, Kafshounchi M, Tanoumand A. [Age-specific prevalence of antibodies to hepatitis A in rural and urban population of Malekan city]. Medical Science Journal of Islamic Azad Univesity-Tehran Medical Branch. 2007;17(1):41-4. Persian.
  • 14. Ataei B, Nokhoudian Z, Javadi AA, Kasaeian N, Farajzadegan Z, Shoaei P, et al. [Seroepidemiology of hepatitis A virus infections in Over 6-years population in Isfahan–Iran: A community-based study]. J Isfahan Med Sch. 2007;25:46-73. Persian.
  • 15. Saffar MJ, Abedian O, Ajami A, Abedian F, Mirabi AM, Khalilian AR, et al. Age-specific seroprevalence of anti-hepatitis a antibody among 1-30 years old population of savadkuh, mazandaran, iran with literature review. Hepat Mon. 2012;12(5):326-32. doi: 10.5812/hepatmon.6035. [PubMed: 22783344]. [PubMed Central: PMC3389358].
  • 16. Farajzadegan Z, Hoseini SG, Kelishadi R, Jamshidi F, Nokhodian Z, Noori R, et al. Systematic review and meta-analysis on the age-specific seroprevalence of hepatitis A in Iran. J Res Med Sci. 2014;19(Suppl 1):S56-63. [PubMed: 25002897]. [PubMed Central: PMC4078371].
  • 17. European Centre for Disease Prevention and Control. Hepatitis A virus in the EU/EEA, 1975-2014. Stockholm: ECDC; 2016.
  • 18. Abdolvahab M, Behnaz K, Sima B, M T. Hepatitis a in young adults in the golestan province, northeast of iran. J Glob Infect Dis. 2010;2(2):198-9. doi: 10.4103/0974-777X.62862. [PubMed: 20606982]. [PubMed Central: PMC2889666].
  • 19. Mostafavi N, Kelishadi R, Kazemi E, Ataei B, Yaran M, Motlagh ME, et al. Comparison of the Prevalence and Risk Factors of Hepatitis A in 10 to 18-Year-Old Adolescents of Sixteen Iranian Provinces: The CASPIAN-III Study. Hepat Mon. 2016;16(9). e36437. doi: 10.5812/hepatmon.36437. [PubMed: 27822259]. [PubMed Central: PMC5091029].
  • 20. Merat S, Rezvan H, Nouraie M, Abolghasemi H, Jamali R, Amini-Kafiabad S, et al. Seroprevalence and risk factors of hepatitis A virus infection in Iran: a population based study. Arch Iran Med. 2010;13(2):99-104. [PubMed: 20187662].
  • 21. Mohebbi SR, Rostami Nejad M, Tahaei SM, Pourhoseingholi MA, Habibi M, Azimzadeh P, et al. Seroepidemiology of hepatitis A and E virus infections in Tehran, Iran: a population based study. Trans R Soc Trop Med Hyg. 2012;106(9):528-31. doi: 10.1016/j.trstmh.2012.05.013. [PubMed: 22835757].
  • 22. Noroozi M, Moradi F, Hasanzadeh A, Banazadegan R, Basiri MR, Ramezani A, et al. [Seroprevalence of hepatitis A and hepatitis E in Qom province, 2011]. Iran J Infect Dis Trop Med. 2012;17(58):19-23. Persian.
  • 23. Taghavi SA, Hosseini Asl MK, Talebzadeh M, Eshraghian A. Seroprevalence study of hepatitis A virus in Fars province, southern Iran. Hepat Mon. 2011;11(4):285-8. [PubMed: 22706273]. [PubMed Central: PMC3206696].
  • 24. Farzadegan H, Shamszad M, Noori-Arya K. Epidemiology of viral hepatitis among Iranian population--a viral marker study. Ann Acad Med Singapore. 1980;9(2):144-8. [PubMed: 7425524].
  • 25. Saffar MJ, Hemmatabady M. [Hepatitis A Seroepidemiology among 1-15 years old children in Sari Iran 1997]. Mazandaran Univ Med Sci J. 1999;9(22-23):1-6. Persian.
  • 26. Khodaei E. Hepatitis A seroepidemiology in Tehranian children less than 14 years old. 7th Congress of Infectious Diseases and Tropical Medicine. Babolsar. 1998. 33 p.
  • 27. Salehi M, Sanei Moghaddam E. [Seroepidemiology of Hepatitis A in population under 30-years-old in rural areas of Zabol]. Guil Univ Med Sci J. 2001;10(37-38):26-9. Persian.
  • 28. Ataei B, Javadi AA, Nokhodian Z, Kassaeian N, Shoaei P, Farajzadegan Z, et al. HAV in Isfahan province: a population-based study. Trop Gastroenterol. 2008;29(3):160-2. [PubMed: 19115608].
  • 29. Sofian M, Aghakhani A, Farazi AA, Banifazl M, Etemadi G, Azad-Armaki S, et al. Seroepidemiology of hepatitis A virus in children of different age groups in Tehran, Iran: implications for health policy. Travel Med Infect Dis. 2010;8(3):176-9. doi: 10.1016/j.tmaid.2010.02.004. [PubMed: 20541138].
  • 30. Elizee PK, Alavian SM. Prevention of hepatitis a virus infection, need to vaccinate or not? Int J Prev Med. 2013;4(8):863-5. [PubMed: 24049610]. [PubMed Central: PMC3775161].
  • 31. Salahei M, Ansari Moghaddam A, Sanei Moghaddam E, Khosravi S, Hajibeigi B, Alavian SM. The epidemiological pattern of acute viral hepatitis in Tehran and Zahedan: A comparison study. Gastroenterol Hepatol from bed to bench. 2009;3(1):33-6. doi: 10.22037/ghfbb.v3i1.67.
  • 32. Movahedi M, Haghdoost AA, Pournik O, Hajarizadeh B, Fallah MS. Temporal variations of health indicators in Iran comparing with other Eastern Mediterranean Region countries in the last two decades. J Public Health (Oxf). 2008;30(4):499-504. doi: 10.1093/pubmed/fdn071. [PubMed: 18772146].
  • 33. Lednar WM, Lemon SM, Kirkpatrick JW, Redfield RR, Fields ML, Kelley PW. Frequency of illness associated with epidemic hepatitis A virus infections in adults. Am J Epidemiol. 1985;122(2):226-33. [PubMed: 3860002].
  • 34. Tseng SL, Hsieh YC, Huang YL, Huang YC, Hung YT, Huang YC. Hepatitis A virus seroepidemiology of elementary school children in New Taipei City in Taiwan. J Microbiol Immunol Infect. 2016;49(5):743-8. doi: 10.1016/j.jmii.2014.08.022. [PubMed: 25442870].
  • 35. Vancelik S, Guraksin A, Alp H. Hepatitis A seroepidemiology in Eastern Turkey. East Afr Med J. 2006;83(2):86-90. [PubMed: 16708879].
  • 36. Tsai CF, Lin DB, Chen SC, Chang YH, Chen CY, Lin JB. Seroepidemiology of hepatitis A virus infection among schoolchildren in Taiwan. J Med Virol. 2011;83(2):196-200. doi: 10.1002/jmv.22000. [PubMed: 21181912].
  • 37. Al-Aziz AM, Awad MA. Seroprevalence of hepatitis A virus antibodies among a sample of Egyptian children. East Mediterr Health J. 2008;14(5):1028-35. [PubMed: 19161074].
  • 38. Campagna M, Maria Mereu N, Mulas L, Pilia R, Francesca Piazza M, Spada L, et al. Pattern of Hepatitis A Virus Epidemiology in Nursing Students and Adherence to Preventive Measures at Two Training Wards of a University Hospital. Hepat Mon. 2016;16(2). e34219. doi: 10.5812/hepatmon.34219. [PubMed: 27195012]. [PubMed Central: PMC4867361].
  • 39. Hoseini SG, Kelishadi R, Ataei B, Yaran M, Motlagh ME, Ardalan G, et al. Seroprevalence of hepatitis A in Iranian adolescents: is it time to introduce a vaccine? Epidemiol Infect. 2016;144(2):291-6. doi: 10.1017/S0950268815001302. [PubMed: 26083105].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments